Amanda Cano

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 132 publications

Lactoferrin Levels in Cerebrospinal Fluid Exhibit Differential Associations with Alzheimer's Disease.

Lactoferrin Levels in Cerebrospinal Fluid Exhibit Differential Associations with Alzheimer's Disease.

Journal: Research square

Published: July 17, 2026

Lactoferrin Levels in Cerebrospinal Fluid Exhibit Differential Associations with Alzheimer's Disease.

Lactoferrin Levels in Cerebrospinal Fluid Exhibit Differential Associations with Alzheimer's Disease.

Journal: Research square

Published: July 17, 2026

Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States.

Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States.

Journal: medRxiv : the preprint server for health sciences

Published: July 03, 2026

Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism.

Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism.

Journal: Frontiers in aging neuroscience

Published: May 07, 2026

Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease.

Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease.

Journal: Science translational medicine

Published: April 29, 2026

Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia.

Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia.

Journal: The journal of prevention of Alzheimer's disease

Published: April 07, 2026

When treatment becomes risk: polypharmacy and inappropriate prescribing in cognitive impairment in 2379 consecutive patients from a memory clinic.

When treatment becomes risk: polypharmacy and inappropriate prescribing in cognitive impairment in 2379 consecutive patients from a memory clinic.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 26, 2026

Human CSF proteogenomics links genetic variation to neurodegenerative disease proteins.

Human CSF proteogenomics links genetic variation to neurodegenerative disease proteins.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2026

Listening for Alzheimer's clues: machine learning analysis of multidomain speech features for cognitive impairment screening.

Listening for Alzheimer's clues: machine learning analysis of multidomain speech features for cognitive impairment screening.

Journal: Frontiers in aging neuroscience

Published: February 24, 2026

Epigallocatechin-3-gallate attenuates colistin-induced neuro and nephrotoxicity by preserving mitochondrial function and reducing oxidative stress.

Epigallocatechin-3-gallate attenuates colistin-induced neuro and nephrotoxicity by preserving mitochondrial function and reducing oxidative stress.

Journal: Biochemical pharmacology

Published: February 24, 2026

CSF turnover reshapes biomarker interpretation in neurodegeneration studies.

CSF turnover reshapes biomarker interpretation in neurodegeneration studies.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics.

Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics.

Journal: Frontiers in microbiology

Published: January 13, 2026

Showing 1-12 of 132

Last Updated: 09/26/2026